The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheron, A.
Right arrow Articles by Baud, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheron, A.
Right arrow Articles by Baud, L.
The Journal of Immunology, 2004, 172: 7677-7683.
Copyright © 2004 by The American Association of Immunologists

15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Glucocorticoid Binding and Signaling in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Independent Process1

Adeline Cheron, Julie Peltier, Joëlle Perez, Agnès Bellocq, Bruno Fouqueray and Laurent Baud2

Institut National de la Santé et de la Recherche Médicale, Unité 489, Service d’Explorations Fonctionnelles Multidisciplinaires, AP-HP Hôpital Tenon, Paris, France

15-Deoxy-{Delta}12,14-PGJ2 (15d-PGJ2) is involved in the control of inflammatory reaction. We tested the hypothesis that 15d-PGJ2 would exert this control in part by modulating the sensitivity of inflammatory cells to glucocorticoids. Human U937cells and mouse RAW 264.7 cells were exposed to 15d-PGJ2, and binding experiments were performed with [3H]dexamethasone as a glucocorticoid receptor (GR) ligand. 15d-PGJ2 caused a transient and concentration-dependent decrease in [3H]dexamethasone-specific binding to either cells through a decrease in the number of GR per cell without significant modification of the Kd value. These changes were related to functional alteration of the GR rather than to a decrease in GR protein. They did not require the engagement of peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}), because the response to 15d-PGJ2 was neither mimicked by the PPAR{gamma} agonist ciglitazone nor prevented by the PPAR{gamma} antagonist bisphenol A diglycidyl ether. 15d-PGJ2 altered GR possibly through the interaction of its cyclopentenone ring with GR cysteine residues because the cyclopentenone ring per se could mimic the effect of 15d-PGJ2, and modification of GR cysteine residues with methyl methanethiosulfonate suppressed the response to 15d-PGJ2. Finally, 15d-PGJ2-induced decreases in glucocorticoid binding to GR resulted in parallel decreases in the ability of GR to activate the transcription of a glucocorticoid-inducible reporter gene and to reduce the expression of monocyte chemoattractant protein-1. Together these data suggest that 15d-PGJ2 limits glucocorticoid binding and signaling in monocytes/macrophages through a PPAR{gamma}-independent and cyclopentenone-dependent mechanism. It provides a way in which 15d-PGJ2 would exert proinflammatory activities in addition to its known anti-inflammatory activities.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Ialenti, G. Grassia, P. Di Meglio, P. Maffia, M. Di Rosa, and A. Ianaro
Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway
Mol. Pharmacol., May 1, 2005; 67(5): 1620 - 1628.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.